ArriVent BioPharma, Inc. 8-K

Accession 0001104659-26-024112

Filing information

CIK: 0001868279
Report date: 2026-03-05
Filing date: 2026-03-05
Form: 8-K
Primary document: avbp-20260305x8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.